Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG plus routine treatment versus routine treatment alone in repeated unexplained IVF failure
IRCT20120215009014N217Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of immune globulin in infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Th17 serum level, Th1:Th2 ratio and 1 more. Started Mar 2017; status: completed.
02
Drugs
immune globulin
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20120215009014N217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N217.